Elmiron Lawsuit – Vision Loss Compensation & Legal Help

Elmiron Lawsuit – Vision Loss Compensation & Legal Help

Elmiron lawsuits allege that long-term Elmiron exposure causes maculopathy. This is an eye disorder that affects the central part of the retina and can lead to blindness.

Individuals who have taken Elmiron or suffered serious eye damage such as maculopathy, are represented by our law firm.

Since 1955, we have been representing drug companies in lawsuits. We teach over 1,500 lawyers how to handle these cases each year. We are listed in Best Lawyers in America as well as The National Trial Lawyers Hall of Fame.

Elmiron Lawsuit – Vision Loss Compensation & Legal Help

Elmiron lawsuits allege that long-term Elmiron exposure causes maculopathy. This is an eye disorder that affects the central part of the retina and can lead to blindness.

Individuals who have taken long-term use of Elmiron or suffered serious eye damage such as maculopathy, are represented by our law firm.

Since 1955, we have been representing drug companies in lawsuits. We teach over 1,500 lawyers how to handle these cases each year. We are listed in Best Lawyers in America as well as The National Trial Lawyers Hall of Fame.

Elmiron is the brand for pentosane-polysulfate sodium. It is used to treat interstitial cystitis (or “bladder pain syndrome”), a condition that causes chronic bladder pain, urgency and pain during sexual activity.

The American Academy of Ophthalmology published an article in 2018 about six patients who suffered from pigmentary maculopathy of unknown cause after chronic exposure to Elmiron (pentosan-polysulfate sodium) for interstitial cystitis.

One of the authors updated the study in 2019, stating that ten Emory Eye Center patients had been diagnosed with the same problem. Individuals in the study reported a loss of low-light vision, generalized dimming, difficulty reading and general near-vision difficulties as their primary complaints.

Elmiron Lawsuit – Vision Loss Compensation & Legal Help

Elmiron lawsuits allege that long-term Elmiron exposure causes maculopathy. This is an eye disorder that affects the central part of the retina and can lead to blindness.

Individuals who have taken Elmiron or suffered serious eye damage such as maculopathy, are represented by our law firm.

Since 1955, we have been representing drug companies in lawsuits. We teach over 1,500 lawyers how to handle these cases each year. We are in The Best Lawyers in America, and The National Trial Lawyers Hall of Fame.

What do we know about the Elmiron Lawsuits.

Elmiron is the brand name for pentosane polysulfate sodium. It is utilized to treat a condition known as interstitial cystitis (“IC”), better known as “bladder pain syndrome.” IC is a very poorly understood condition, the symptoms of which include chronic bladder pain, urinary frequency, urinary urgency, and painful sexual intercourse.

The American Academy of Ophthalmology published an article in 2018 about six patients who suffered from pigmentary maculopathy of unknown cause after chronic exposure to Elmiron (pentosan-polysulfate sodium) for interstitial cystitis.

One of the authors updated the study in 2019, stating that ten Emory Eye Center patients had been diagnosed with the same problem. Individuals in the study reported a loss of low-light vision, generalized dimming, difficulty reading and general near-vision difficulties as their primary complaints.

Elmiron: The Main Legal Issues

The main legal question is whether Elmiron’s manufacturer failed to warn patients and doctors about possible vision-related side effects.

Elmiron can cause severe vision damage and has not been proven to treat interstitial cystitis. In 1990, Elmiron was first tested in clinical trials. However, the drug’s efficacy was doubtful. One FDA reviewer stated that Elmiron was not effective in treating interstitial cystitis.

Elmiron Lawsuit – Vision Loss Compensation & Legal Help

Elmiron lawsuits allege that long-term Elmiron exposure causes maculopathy. This is an eye disorder that affects the central part of the retina and can lead to blindness.

Individuals who have taken Elmiron or suffered serious eye damage such as maculopathy, are represented by our law firm.

Since 1955, we have been representing drug companies in lawsuits. We teach over 1,500 lawyers how to handle these cases each year. We are listed in Best Lawyers in America as well as The National Trial Lawyers Hall of Fame.

What do we know about the Elmiron Lawsuits.

Elmiron is the brand name for pentosane polysulfate sodium. It is utilized to treat a condition known as interstitial cystitis (“IC”), better known as “bladder pain syndrome.” IC is a very poorly understood condition, the symptoms of which include chronic bladder pain, urinary frequency, urinary urgency, and painful sexual intercourse.

The American Academy of Ophthalmology published an article in 2018 about six patients who suffered from pigmentary maculopathy of unknown cause after chronic exposure to Elmiron (pentosan-polysulfate sodium) for interstitial cystitis.

One of the authors updated the study in 2019, stating that ten Emory Eye Center patients had been diagnosed with the same problem. Individuals in the study reported a loss of low-light vision, generalized dimming, difficulty reading and general near-vision difficulties as their primary complaints.

Elmiron: The Main Legal Issues

The main legal question is whether Elmiron’s manufacturer failed to warn patients and doctors about possible vision-related side effects.

Elmiron can cause severe vision damage and has not been proven to treat interstitial cystitis. In 1990, Elmiron was first tested in clinical trials. However, the drug’s efficacy was doubtful. One FDA reviewer stated that Elmiron was not effective in treating interstitial cystitis.

Elmiron Side Effects and Injuries

Recent peer-reviewed, post-marketing studies have shown that Elmiron has been linked to maculopathy. Maculopathy can cause blindness, central vision loss and impaired vision.

The “pigmentary macularopathy” is the form of macular disease that has been associated with Elmiron. Damage to the macula at the back of the eye is known as maculopathy. A variety of visual symptoms can be experienced by patients with maculopathy, including blurred or black spots, poor vision or dimming, distortion of images and legal blindness.

U.S. Food & Drug Administration ( FDA ) encourages people to report unexpected side effects and adverse events with drugs and medical devices. You can do this online by filling out a Voluntary Reporting form.